
Health care providers can manage “fake news” about statins, including their indications and misinformation regarding liver and kidney damage.

Health care providers can manage “fake news” about statins, including their indications and misinformation regarding liver and kidney damage.

Bempedoic acid is indicated as an adjunct to diet and maximally tolerated statin therapy for adults with heterozygous familial hypercholesterolemia or established atherosclerotic cardiovascular disease who require additional lowering of low-density lipoprotein-cholesterol.

Patients with atherosclerotic cardiovascular disease who were already receiving statin therapy had a reduction in adverse cardiovascular outcomes with earlier initiation of evolocumab.

Sodium oxybate is currently being studied for long-term safety and tolerability in the open label RESTORE clinical study in adults with narcolepsy.

The efficacy of 2 doses against Omicron infection was highest when the second vaccine dose was given in the third trimester of pregnancy compared with the first or second trimesters.

Sarah Gray, BPharm, an integrative nutritionist and the Nutrition Pharmacist, discusses the importance of National Nutrition Month.

Investigators noted medication prescription disparities among patients with dementia despite factoring for age and sex.

The partnership to deliver HIV medications will reduce transportation and access barriers for patients, especially in underserved communities.

Just a few short years ago there was a pharmacist glut; is there really a shortage now, or is a deeper labor market contortion occurring?

Due to the success of mRNA technology with COVID-19, there has been a significant increase in research looking into utilizing mRNA technology, and more specifically, how it can help to advance vaccine development.

Vitamin D may reduce the risk of dementia because it clears amyloid that accumulates in the brain.

Bruce Berger, PhD, president of Berger Consulting LLC, discusses how pharmacists should best use motivational interviewing for patients.

Pharmacy Times® commits to incorporating DEI concepts into our coverage and focusing on social determinants of health (SDOH).

The FDA set a Prescription Drug User Fee Act for May 2023 for Pfizer’s respiratory syncytial virus bivalent vaccine candidate.

The effectiveness of 2 doses against Omicron infection was highest when the second dose was given in the third trimester of pregnancy compared with the first or second trimesters.

Clinical guidelines suggest screening for cardiovascular risk factors post-partum in women, however, these recommendations are not closely followed, a new study suggests.

The company is also launching Rezvoglar, a biosimilar to Lantus injection, for $92 per 5-pack of KwikPens.

Sarilumab is a fully human monoclonal antibody indicated for patients with polymyalgia rheumatica who had an inadequate response to corticosteroids or are unable to tolerate corticosteroid taper.

Study results indicates that the injectable antiretroviral therapy can benefit patients who are historically underserved and may face treatment barriers, including those with mental illness.

The set of principles seeks to improve publication patterns to show the value of the pharmacist and how journals can strengthen pharmacy practice as a scientific discipline.

Because 1 thing is not enough.

The drug is indicated for moderate to severe plaque psoriasis.

Companies seek FDA approval for individuals aged 12 years and older to receive vaccinations for their primary series.

Many laws also allow physicians to decide which information they disclose to guardians or fail to address inadvertent breaches of confidentiality through insurance billing and claims.

Patients who had relapsed or treatment-resistant cancer at baseline, or those who had more severe acute COVID-19 infections, were less likely to develop long COVID-19.

Cases discuss patients with medication allergies and drug interactions.

Products include acne patches and immune boosting power.

AI models can predict pharmacy foot traffic and peak service times, and even analyze patient histories to single out who picks up their prescriptions on time.

Zavegepant is the first calcitonin gene-related peptide receptor for migraines in development as an intranasal formulation studied in a phase 3 trial.

Phase 3 trial results indicate efficacy against respiratory syncytial virus-lower respiratory tract disease in individuals aged 60 years and older.